The only chart anyone should look at for this sort of asymmetrical opportunity (and for peace of mind) is the monthly chart. Obviously with appropriate capital management mitigation in place.
All the basic technicals suggest a continuation of the uptrend.
- Trading aggressively off the triple bottom.
- 60.36.12 month MAs continue to diverge after the 36 crossed the 60 in July.
- Retest of old monthly tops dusted in Aug, Oct, Nov.
- Volume trend solidly up.
- MACD continue to diverge and a long way from magnitude in 2011.
- RSI momentum has held the trend line from June '16 bottom and remains a long way from the 2011 overbought condition.
One thing this stock is great at, is sucking in traders on the open, before selling off like today. The annoucement was good but not 18% good in my opinion. Irrespective, sleeping requires having the right time perspective and if you're in early enough, then the monthly is the one to focus on.
GLTAH!
- Forums
- ASX - By Stock
- Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
The only chart anyone should look at for this sort of...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B |
Open | High | Low | Value | Volume |
$1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.57 | 39613 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5127 | 1.565 |
3 | 15000 | 1.560 |
1 | 507 | 1.550 |
2 | 8950 | 1.545 |
5 | 81611 | 1.540 |
Price($) | Vol. | No. |
---|---|---|
1.570 | 39613 | 3 |
1.575 | 6173 | 1 |
1.580 | 119061 | 10 |
1.585 | 5500 | 1 |
1.590 | 91149 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online